Literature DB >> 17982705

Regulation of in vitro vascular calcification by BMP4, VEGF and Wnt3a.

Lyudmila Mikhaylova1, Jennifer Malmquist, Maria Nurminskaya.   

Abstract

Vascular calcification is a common clinical complication of cardiovascular disease, diabetes and end-stage renal failure, associated with significant morbidity and mortality. In this study we demonstrate that factors secreted by the hypertrophic chondrocytes induce matrix mineralization and osteoblastic transformation in cultured mouse vascular smooth muscle cells (VSMCs). In addition, these factors render VSMCs responsive to BMP4 and Wnt3a ligands. Neither BMP-4 nor Wnt3a could induce mineralization in short-term (up to 8 days) cultures of primary mouse VSMCs. However, both ligands act synergistically with the chondrocyte-conditioned medium causing a further increase in VSMC calcification. Finally, we show that commitment of VSMCs towards the BMP-regulated mineralization can be induced by the chondrocyte-secreted bone anabolic factor VEGF. In addition, expression profiling suggests a novel role in vascular calcification for the matrix proteins previously known to regulate bone formation and mineralization (including MMP3, fibulin, 11betahydroxysteroid dehydrogenase 1 and retinoic acid receptor responder 2). The results of this study may contribute to further understanding of the cellular mechanisms responsible for vascular calcification and provide important information for the treatment of this pathology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982705     DOI: 10.1007/s00223-007-9073-6

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  23 in total

1.  Amelotin is expressed in retinal pigment epithelium and localizes to hydroxyapatite deposits in dry age-related macular degeneration.

Authors:  Dinusha Rajapakse; Katherine Peterson; Sanghamitra Mishra; Jianguo Fan; Joshua Lerner; Maria Campos; Graeme Wistow
Journal:  Transl Res       Date:  2020-02-27       Impact factor: 7.012

2.  Transglutaminase 2-mediated activation of β-catenin signaling has a critical role in warfarin-induced vascular calcification.

Authors:  Kelly E Beazley; Stephanie Deasey; Florence Lima; Maria V Nurminskaya
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-27       Impact factor: 8.311

Review 3.  A single gene connects stiffness in glaucoma and the vascular system.

Authors:  Teresa Borrás
Journal:  Exp Eye Res       Date:  2016-09-01       Impact factor: 3.467

4.  Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein.

Authors:  Kelly E Beazley; Saman Eghtesad; Maria V Nurminskaya
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

5.  Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia.

Authors:  Domenick A Prosdocimo; Steven C Wyler; Andrea M Romani; W Charles O'Neill; George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-16       Impact factor: 4.249

6.  Calciphylaxis as a Catastrophic Complication in a Patient with POEMS Syndrome.

Authors:  Akiyo Hineno; Tomomi Kinoshita; Michiaki Kinoshita; Fuyuko Arakura; Ko-Suke Naito; Yasuhiro Shimojima; Masayuki Matsuda; Kunihiro Yoshida; Shu-Ichi Ikeda
Journal:  Case Rep Neurol       Date:  2009-12-02

7.  Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis.

Authors:  Paolo Poggio; Rachana Sainger; Emanuela Branchetti; Juan B Grau; Eric K Lai; Robert C Gorman; Michael S Sacks; Alessandro Parolari; Joseph E Bavaria; Giovanni Ferrari
Journal:  Cardiovasc Res       Date:  2013-03-12       Impact factor: 10.787

Review 8.  Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?

Authors:  P Anagnostis; A Karagiannis; A I Kakafika; K Tziomalos; V G Athyros; D P Mikhailidis
Journal:  Osteoporos Int       Date:  2008-05-29       Impact factor: 4.507

9.  Two sides of MGP null arterial disease: chondrogenic lesions dependent on transglutaminase 2 and elastin fragmentation associated with induction of adipsin.

Authors:  Kelly E Beazley; Steven Reckard; Dmitry Nurminsky; Florence Lima; Maria Nurminskaya
Journal:  J Biol Chem       Date:  2013-09-13       Impact factor: 5.157

Review 10.  Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis?

Authors:  Tri Q Nguyen; Roel Goldschmeding
Journal:  Pharm Res       Date:  2008-02-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.